Articles

Ensuring Diversity in COVID-19 Vaccine Registration Trials

Clinical Research

With significant variations in the effects of COVID-19 among various ethnic, racial, and minority groups, how do we ensure vaccine trials are accurately establishing efficacy and safety across all patient populations? Beyond the ethical considerations, diversity is a medical and scientific imperative. This peer-reviewed article identifies tools and considerations for achieving representative diversity in enrolment for COVID-19 vaccine registration trials.

Articles

Regulating Healthcare Products in Canada

Regulatory

Read this article about findings from the most recent Biopharma Confidence Index that show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence.

Articles

Regulatory Response to Accelerate COVID-19 Drug Development

Regulatory

regulatory COVID-19

In a recent Journal for Clinical Studies article, Aman Khera and Henry J. Riordan, Ph.D., discuss recent guidance, operational processes and best practices designed by regulatory bodies to accelerate drug product development during COVID-19.